The Recall Desk
SevereFDA (Drugs)·D-1655-2019·Announced 2019-08-14

RXQ Compounding Recalls Ephedrine Syringes Due to Sterility Concerns

RXQ Compounding LLC is recalling Ephedrine 5mg/mL syringes nationwide because the product lacks assurance of sterility.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score under the rubric for drug recalls involving potential serious health consequences.

Plain-English summary

RXQ Compounding LLC is recalling Ephedrine 5mg/mL (PF) syringes, 5 mL per syringe, under NDC 70731-0201-85. The recall is being conducted because the product lacks assurance of sterility.

The affected product was distributed nationwide in the United States. All lots within the expiry date are included in this recall.

Consumers and healthcare providers should stop using the recalled product and contact their pharmacist or healthcare provider for guidance on replacement or disposal.

The recalled product

Product
EPHEDRINE 5MG/ML (PF) SYRINGE, 5 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0201-85
Manufacturer
RXQ Compounding LLC
Category
Drug — Injectable Sterile Product
Hazard

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots within expiry

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 86 recalled by RXQ Compounding LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 86 products in this recall →

Related recalls

Same manufacturer · RXQ Compounding LLC

See all →

Same hazard · sterility failure

See all →